Skip to content
Home/Companies/Biotech/PsiOxus Therapeutics
PT

PsiOxus Therapeutics

Biotech·UK·Active·5yr hold

PsiOxus Therapeutics is a biotech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns PsiOxus Therapeutics?

PsiOxus Therapeutics is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021.

Hand-verified · updated 2026-06-30

Rosetta Capital
Investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries

Key facts

HQUK
SectorBiotech
StatusActive

More from Rosetta Capital V

Other portfolio companies in the same fund.

Carrick Therapeutics
Active
BiotechIreland· 2021
Immunocore
Active
BiotechUK· 2021
Inivata
Active
HealthTechUK· 2021
Mereo BioPharma
Active
BiotechUK· 2021
Mission Therapeutics
Active
BiotechUK· 2021
ReNeuron
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings